Bronstein, Goertz & Grossman LLC

Bronstein, Goertz & Grossman LLC

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) — Lawyer Announcement – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AlloVir Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR) and certain of its officers.

Category definition:

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired AlloVir securities between March 22, 2022 and December 21, 2023, inclusive (the “Class Period”). ). These investors are encouraged to join this case by visiting the company’s website: bgandg.com/ALVR.

Case details:

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding AlloVir’s business, operations, and future prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Phase III studies of posoleucel were unlikely to meet their primary endpoints; (2) As a result, AlloVir was likely to eventually discontinue phase III studies of posoleucel; (3) accordingly, AlloVir overestimated the effectiveness and clinical and/or commercial prospects of posoleucel; and (4) as a result, AlloVir’s public statements were materially false and misleading at all relevant times.

What then?

A class action lawsuit has already been filed. If you would like to review a copy of the complaint, you can visit the company’s website: bgandg.com/ALVR Or you may contact Peretz Bronstein, Esq. Or our law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660. If you suffer a loss in AlloVir, you have until March 19, 2024 to ask the court to appoint you as lead plaintiff. Your ability to participate in any recovery does not require that you serve as lead plaintiff.

There is no cost to you

We represent investors in class actions on a contingency fee basis. This means that we will ask the court to reimburse us for out-of-pocket expenses and attorney fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Goertz and Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud and shareholder derivative litigation. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Lawyer advertisement. Previous results do not guarantee similar results.

communication:

Bronstein, Goertz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

332-239-2660 | info@bgandg.com

    (Tags for translation)Bronstein

You may also like...

Leave a Reply